Utility of vaginal vault cytology in the local recurrence of cervical cancer.

ABSTRACT:

Background

In Japan, 8000 women were newly diagnosed with cervical cancer in 2018. The healthcare insurance policy in Japan allows physicians to utilize vaginal volt cytology tests and serum biomarker measurement at every visit and imaging analysis at an adequate interval with screening for recurrence after initial treatment. However, the major surveillance guidelines published in the United States and European countries recommend focusing on pelvic examinations and symptom reviews to avoid unnecessary tests. This study aimed to reassess the benefits of standard surveillance methods adopted in this study by retrospective analysis.

Methods

From January 2009 to December 2015, the medical records of patients with recurrence who were initially diagnosed with International Federa

SUBMITTER: Nakamura K 

PROVIDER: S-EPMC10116747 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature